On August 7, 2025, the U.S. Food and Drug Administration (FDA) announced FDA PreCheck, a new two-phase framework aimed at bolstering the domestic pharmaceutical supply chain by streamlining the regulatory process for U.S.-based drug manufacturing facilities. Notably, the announcement also included information regarding an upcoming public meeting about the PreCheck framework and opportunity to comment and
Latest Post
More Posts
FDA Release of Complete Response Letters Raises Confidentiality, Disclosure Questions But Offers Insights for Development
FDA Publishes New Draft Guidance Essentially Clarifying that the Human Drug GMP Guidelines (ICH Q7) Apply to the Manufacture of Veterinary Active Pharmaceutical Ingredients
U.S. and EU Expand Mutual Recognition Agreement to Include Animal Drugs
Subscribe: Subscribe via RSS
Blogs
Firm/Org